Formulation and stability evaluation of an extemporaneously prepared baclofen suspension (1 mg/mL)
Authors:
- 19 July 2021
- journal article
- research article
- Published by Wiley in Journal of Pharmacy Practice and Research
- Vol. 51 (4) , 314-320
Abstract
Background: Baclofen is prescribed for both adults and children as a muscle relaxant, but no data exists to support an appropriate lower‐dose extemporaneously compounded oral liquid suitable for young children in New Zealand.Aim: This study aimed to determine the stability of 1 mg/mL baclofen oral suspension over 30 days.Method: Baclofen suspensions were compounded (n = 6 per formulation) using suspending vehicles Ora‐Blend® (OB) or Ora‐Blend sugar‐free® (OB SF) and stored at either 25°C/60% relative humidity or 2–8°C for 30 days. Organoleptic properties, sedimentation volume ratio, ease of redispersion, pH and baclofen content were determined.Results: Formulations required 2–3 inversions to redisperse at each time point. A colour change was observed from day 14 in the OB suspensions stored at both temperatures, likely due to the Maillard reaction, whereas no colour change was observed in any OB SF suspensions. The pH of all formulations remained between 4.5 and 4.6. Both OB and OB SF suspensions retained >90% of the initial baclofen concentration over 30 days.Conclusion: Although baclofen 1 mg/mL suspensions prepared in both OB and OB SF retained sufficient baclofen to be considered chemically stable in both storage conditions over the study period, OB SF is recommended as a preferred vehicle over OB formulations due to the colour change observed.Keywords
This publication has 13 references indexed in Scilit:
- Review of the physicochemical methods applied in the investigation of the maillard reaction in pharmaceutical preparationsJournal of Drug Delivery Science and Technology, 2020
- Extemporaneously compounded medicinesAustralian Prescriber, 2017
- Formulations for children: problems and solutionsBritish Journal of Clinical Pharmacology, 2015
- General Principles of Suspensions2009
- Assessment of Feasibility of Maillard Reaction between Baclofen and Lactose by Liquid Chromatography and Tandem Mass Spectrometry, Application to Pre Formulation StudiesAAPS PharmSciTech, 2009
- A Perspective on the Maillard Reaction and the Analysis of Protein Glycation by Mass Spectrometry: Probing the Pathogenesis of Chronic DiseaseJournal of Proteome Research, 2008
- Extemporaneous drug formulationsClinical Therapeutics, 2008
- Amlodipine Besylate–Excipients Interaction in Solid Dosage FormPharmaceutical Development and Technology, 2004
- Selection of solid dosage form composition through drug–excipient compatibility testingJournal of Pharmaceutical Sciences, 1999
- BaclofenAnalytical Profiles of Drug Substances, 1985